Target intelligence / Profile preview

TBC1 domain family member 9B (TBC1D9B)

Target
TBC1D9B
Molecular classification
Enzyme (specifically, Rab GTPase-activating protein), Other (regulatory protein involved in membrane trafficking)
01

Overview

TBC1 domain family member 9B (TBC1D9B) is a large (~140 kDa) protein with two N-terminal GRAM domains, a central TBC domain, and a C-terminal EF hand motif[1]. It functions primarily as a GTPase-activating protein for Rab11a, modulating its activity to regulate membrane trafficking—specifically the transcytosis of immunoglobulin A (IgA) in polarized epithelial cells[1][2]. TBC1D9B is also implicated in autophagic flux regulation, interacting with LC3B on autophagosome membranes and potentially ensuring proper autophagosome trafficking and degradation[3]. Although it can interact with additional Rabs (Rab11b, Rab4a, and under certain magnesium conditions, Rab8a), its GAP activity is most pronounced for Rab11a[1][2]. TBC1D9B is not currently considered a direct therapeutic target, nor are there drugs or biomarker applications described in the literature or clinical practice[5][6]. Its biological relevance stems from regulation of protein trafficking and autophagy, and dysfunction may theoretically contribute to cellular transport disorders, but direct disease links have not been established[3][5].

Other names
KIAA0676GRAMD9BTBC1 domain family member 9B (with GRAM domain)TBC1D9B
02

Biological functions

Intracellular protein transportRegulation of Rab GTPase activityRegulation of vesicular trafficking (specifically basolateral-to-apical transcytosis in polarized epithelial cells)Regulation of autophagic flux
03

Disease associations

Other (possible involvement in trafficking dysfunction and autophagy-related processes—no direct links yet established to major disease classes such as cancer or neurodegeneration)

Beyond the preview

Go deeper on TBC1 domain family member 9B (TBC1D9B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TBC1 domain family member 9B (TBC1D9B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call